King Pharmaceuticals®, Inc.
501 Fifth Street
Bristol
Tennessee
37620
United States
Tel: 423-989-8000
Fax: 423-274-8677
Website: http://www.kingpharm.com/
238 articles about King Pharmaceuticals®, Inc.
-
King Pharmaceuticals®, Inc. Appoints John J. Howarth Vice President Investor Relations
6/1/2009
-
King Pharmaceuticals®, Inc. Posts Net Loss, but Results Beat Street
5/11/2009
-
King Pharmaceuticals®, Inc. Presents Safety, Efficacy and Measurement Data from Expanded Pain Portfolio
5/7/2009
-
King Pharmaceuticals®, Inc. And Acura Pharmaceuticals, Inc. Release: Excess Oral Doses of Acurox(R) Tablets are Disliked by Subjects with a History of Opioid Abuse
5/1/2009
-
King Pharmaceuticals®, Inc. CEO Brian Markison's Compensation Falls by Nearly Half in 2008
4/24/2009
-
King Pharmaceuticals®, Inc. to Present at Cowen and Company Health Care Conference
3/13/2009
-
King Pharmaceuticals®, Inc., Acura Pharmaceuticals, Inc. Pain Drug Gets Priority Review
3/3/2009
-
King Pharmaceuticals®, Inc. Reports Year-End and Fourth-Quarter 2008 Financial Results
2/26/2009
-
King Pharmaceuticals®, Inc. Posts Q4 Loss on Charge, Lower Sales
2/26/2009
-
King Pharmaceuticals®, Inc. Plans Webcast to Review Financial Results for the Fourth-Quarter and Year-End 2008 and Provide Strategic Update
2/20/2009
-
King Pharmaceuticals®, Inc. Announces Corporate Restructuring to Reduce Operating Expenses; Reduces Workforce 22%
2/3/2009
-
King Pharmaceuticals®, Inc. Announces Positive Results from a 12-Month Open-Label Safety and Efficacy Study of EMBEDA(TM) Extended Release Capsules
1/30/2009
-
U.S. Court Invalidates King Pharmaceuticals®, Inc. Patents on Skelaxin
1/21/2009
-
FDA Extends Review of King Pharmaceuticals®, Inc.'s Embeda
1/2/2009
-
King Pharmaceuticals®, Inc. Completes Acquisition of Alpharma Inc.
12/30/2008
-
Actavis Acquires Drug, Kadian for Under $127.5M; Extends Specialty Drug Portfolio in U.S.
12/30/2008
-
King Pharmaceuticals®, Inc. Initiates Phase II Clinical Trial Evaluating T-62 as a Treatment for Neuropathic Pain
12/29/2008
-
King Pharmaceuticals®, Inc. Exercises Option to License Fourth Opioid Product From Acura Pharmaceuticals, Inc.
12/29/2008
-
Federal Trade Commission Provisionally Accepts Consent Decree and Terminates Waiting Period for King Pharmaceuticals®, Inc.’s Acquisition of Alpharma Inc.
12/29/2008
-
King Pharmaceuticals®, Inc. Extends Tender Offer for Alpharma Inc.
12/22/2008